申请人:Dugar Sundeep
公开号:US20130303516A1
公开(公告)日:2013-11-14
The present invention relates to novel triazine compounds of formula (1), methods of their preparation, pharmaceutical compositions containing these compounds and the use of these compounds to treat proliferative disorders such as tumors and cancers and also other conditions and disorders related to or associated with dysregulation of PI3 Kinases, PI3 Kinase pathway, mTOR and/or the mTOR pathway.
本发明涉及公式(1)的新型三嗪类化合物,其制备方法、含有这些化合物的药物组合物以及使用这些化合物治疗增殖性疾病,如肿瘤和癌症,以及与PI3激酶、PI3激酶途径、mTOR和/或mTOR途径失调相关或相关的其他状况和疾病。